Home
>
National Drug Code (NDC)
>
Penlac
Penlac - 0187-5180-06 - (ciclopirox)
Drug Information of Penlac
| Product NDC: | 0187-5180 |
| Proprietary Name: | Penlac |
| Non Proprietary Name: | ciclopirox |
| Active Ingredient(s): | 80 mg/mL & nbsp; ciclopirox |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Penlac
| Product NDC: | 0187-5180 |
| Labeler Name: | Valeant Pharmaceuticals North America LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021022 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130501 |
Package Information of Penlac
| Package NDC: | 0187-5180-06 |
| Package Description: | 6.6 mL in 1 BOTTLE, WITH APPLICATOR (0187-5180-06) |
NDC Information of Penlac
| NDC Code | 0187-5180-06 |
| Proprietary Name | Penlac |
| Package Description | 6.6 mL in 1 BOTTLE, WITH APPLICATOR (0187-5180-06) |
| Product NDC | 0187-5180 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ciclopirox |
| Dosage Form Name | SOLUTION |
| Route Name | TOPICAL |
| Start Marketing Date | 20130501 |
| Marketing Category Name | NDA |
| Labeler Name | Valeant Pharmaceuticals North America LLC |
| Substance Name | CICLOPIROX |
| Strength Number | 80 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Decreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA] |
